ASTRO-ACS Clinician Scientist Development Grant (CSDG)
The American Cancer Society (ACS) and the American Society for Radiation Oncology (ASTRO) have partnered to co-fund one Clinician Scientist Development Grant (CSDG). The goal of the ASTRO-ACS CSDG is to foster the research career of a clinician scientist in radiation oncology.
The investigator selected for funding will be required to become a member of ASTRO prior to grant activation.
Grant Overview
The Clinician Scientist Development Grant (CSDG) supports full-time faculty members in becoming independent investigators as clinician scientists. This grant is designed for people trained primarily as clinicians who want to maintain clinical practice and conduct cancer research. Specifically, for this RFA in partnership with ASTRO, the applicant must be in the radiation oncology field.
Eligibility
Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are especially encouraged to apply.
You ARE eligible to submit a proposal if you:
- Are a full-time faculty member at a US academic institution or eligible non-profit
- Have a doctoral degree (or terminal degree for their field), an active clinical license, and participate in clinical care. Applicants may also be board-certified clinical medical physicists.
- Are not a current or former principal investigator (PI) of an individual mentored training grant
- Have NOT had an R-level or equivalent grant as PI
Grant Term and Budget
Awards may be for 3 to 5 years with $135,000 a year for direct costs, plus 8% allowable indirect costs.
Starting January 2024, all ASTRO-CSDG applications (new and resubmissions) must be submitted through the Clinician Scientist Development Grant application in proposalCentral. Applicants will select the ASTRO-CSDG RFA on the cover page of their application.
This RFA will be available again in the Winter 2025 application cycle. Interested applicants may still submit applications to the standard CSDG application for the Summer 2025 cycle.
